PROTALIX BIOTHERAPEUTICS INC (PLX) Stock Balance Sheet
NYSEARCA:PLX • US74365A3095
Current stock price
2.3 USD
+0.02 (+0.88%)
Last:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.65M | 19.76M | 23.63M | 17.10M | 39.00M | |||
| Marketable Securities | 15.72M | 15.07M | 20.93M | N/A | N/A | |||
| Receivables | 14.43M | 2.91M | 5.27M | 4.60M | 3.40M | |||
| Inventories | 21.25M | 21.24M | 19.05M | 16.80M | 18.00M | |||
| Other Current Assets | 1.45M | 1.10M | 1.05M | 6.40M | 1.30M | |||
| Total Current Assets | 66.50M | 60.08M | 69.93M | 44.90M | 61.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.53M | 10.02M | 10.88M | 9.60M | 9.90M | |||
| Other Non-Current Assets | 3.23M | 3.32M | 3.62M | 1.30M | 2.10M | |||
| Total Non-Current Assets | 15.76M | 13.34M | 14.50M | 10.90M | 12.00M | |||
| TOTAL ASSETS | 82.26M | 73.42M | 84.43M | 55.80M | 73.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 20.25M | N/A | N/A | |||
| Accrued Expenses | 10.27M | 12.41M | 12.37M | 11.10M | 15.50M | |||
| Accounts Payable | 5.38M | 4.53M | 4.32M | 5.90M | 7.00M | |||
| Other Current Liabilities | 6.30M | 8.68M | 8.59M | 15.50M | 10.70M | |||
| Total Current Liabilities | 21.95M | 25.62M | 45.53M | 32.40M | 33.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 28.20M | 27.90M | |||
| Other Non-Current Liabilities | 7.41M | 4.58M | 5.33M | 5.80M | 18.60M | |||
| Total Non-Current Liabilities | 7.41M | 4.58M | 5.33M | 34.00M | 46.50M | |||
| TOTAL LIABILITIES | 29.36M | 30.21M | 50.87M | 66.40M | 79.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -379.49M | -378.39M | -381.55M | -389.90M | -374.90M | |||
| Additional Paid In Capital | 432.32M | 421.53M | 415.05M | 379.20M | 368.90M | |||
| Common Shares | 80.00K | 76.00K | 73.00K | 100.00K | 0.00 | |||
| Shares Outstanding | 80.34M | 75.85M | 72.95M | 53.80M | 45.60M | |||
| Tangible Book Value per Share | 0.66 | 0.57 | 0.46 | -0.20 | -0.13 | |||
| Total Shareholders' Equity | 52.91M | 43.21M | 33.57M | -10.60M | -6.00M | |||
| TOTAL LIABILITIES AND EQUITY | 82.26M | 73.42M | 84.43M | 55.80M | 73.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | -2.66 | -4.65 | |||
| Current Ratio | 3.03 | 2.34 | 1.54 | 1.39 | 1.86 | |||
| Return On Assets (ROA) | 6.56% | 3.99% | 9.84% | -26.76% | -37.42% | |||
| Return On Equity (ROE) | 10.20% | 6.79% | 24.76% | N/A | N/A | |||
| Return On Invested Capital (ROIC) | 8.85% | 6.87% | 22.53% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 17.24% | 25.32% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 17.24% | 25.32% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.16